TITLE:
      Naltrexone for Relapse Prevention
SUMMARY:
      This study is to evaluate the safety and effectiveness of an injectable slow releasing
      preparation of naltrexone to reduce alcohol consumption and risk of relapse in
      alcohol-dependent subjects. Individuals will receive either naltrexone or a placebo
      injection for a total of three months, with two subsequent followup visits spanning a 6-
      month period.
ELIGIBILITY CRITERIA:
      Inclusion Criteria:

          -  Meets criteria for alcohol dependence.

          -  Abstinent from alcohol for a period of at least 3 days prior to beginning of study.

          -  Able to read English and complete study evaluations.

          -  Females who are postmenopausal, have had surgical sterilization, or use reliable
             means of birth control.

        Exclusion Criteria:

          -  Meets criteria for dependence on a psychoactive substance other than alcohol and
             nicotine and/or cannabis.

          -  Prior history of opioid dependence.

          -  Regular use of psychoactive drugs including anxiolytics and antidepressants.

          -  Prior treatment with naltrexone.

          -  Current use of disulfiram.

          -  Psychotic or otherwise severely psychiatrically disabled (e.g., suicidal, current
             mania).

          -  Significant underlying medical conditions such as hepatic, cerebral, renal, thyroid,
             or cardiac disease.

          -  Abstinent longer than 28 days prior to randomization.
